Drugs / GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 4
GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00621322 | Apr 2008 → Apr 2009 | tuberculosis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK Biologicals' Candidate Tuberculosis Vaccine (692342) - Formulation 4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00621322 ↗ |
| Modality | Vaccine | “692342 tuberculosis vaccine” NCT00621322 ↗ |
| Route | Intramuscular | “Intramuscular injection, 2 doses” NCT00621322 ↗ |